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Abstract 
Adiponectin is a beneficial adipocyte-secreted hormone, which circulates in a variety of multimeric forms termed low 
and high molecular weight (LMW/HMW). Effectiveness of clinical therapeutic trials which target adiponectin rely on 
accurate determination of circulating total and HMW adiponectin levels but the accuracy may be influenced by 
variations in sample handling processes. The aim of this pilot study was to investigate the effects of delayed processing 
of blood samples on the concentration of total and HMW adiponectin. 
Materials and Methods: Fasting blood samples were collected for analysis of total and HMW adiponectin 
concentrations in EDTA plasma and serum from eight healthy participants. Samples were centrifuged post 15 min 
storage at 4
oC as the comparative „ideal‟ method or after up to 72 h of refrigerated storage or 6 h at room temperature. 
Total and HMW adiponectin concentrations were measured by ELISA. 
Results: Under ideal handling conditions measurements of total and HMW adiponectin concentrations were 
significantly higher in serum than in plasma (mean difference: -1.3 µg/mL [95% CI: -1.6, -1.0], p<0.001; and, -0.6 
µg/mL [95% CI: -0.7, -0.5], p<0.001, respectively). Storage of blood samples at 4
o
C for 72 h resulted in significant 
reductions in concentration of total adiponectin in serum (mean difference: -1.4 µg/mL [95% CI: -2.0, -0.8], p=0.001) 
and HMW adiponectin in plasma (mean difference: -0.6 µg/mL [95%CI: -0.9, -0.2], p=0.007), compared with ideal 
conditions. Further analysis of serum samples showed a significant decrease in total adiponectin concentration after 6 h 
storage at 4
o
C (mean difference: -1.4 µg/mL [95% CI: -2.0, -0.8], p=0.001) compared with ideal conditions. 
Conclusions: Delayed processing of samples may have differential effects on the concentration of total and HMW 
adiponectin in serum or plasma. Larger studies are warranted for clinical intervention trials.  
Keywords: adipokines, adiponectin, protein multimerisation, protein stability  
1. Introduction 
Optimised and standardised handling processes and conditions for blood collection and sample storage for accurate 
“true” concentration estimation of analytes are essential for accurate clinical decisions. However, logistical realities can 
fall far short of these ideals. Given the variability that may be present in handling of samples, particularly in trials 
involving sample collection and processing across multiple centres, there has been considerable interest in determining 
the stability of circulating adiponectin and other analytes in clinical samples under different handling processes and 
conditions. Studies designed to establish the stability of factors such as cytokines (Keustermans, Hoeks, Meerding, 
Prakken, & de Jager, 2013), hormones (Oddoze, Lombard, & Portugal, 2012) and small molecules (Mechanic et al., 
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2013) have produced variable results that reflect a combination of differences between analytes, protocols and methods 
of detection. For example, a recent study looking at stability from peptide fingerprinting using Mass Spectrometry 
found a high level of stability for many of the proteins studied whereas methods that require intact proteins, or at least 
intact antigenic regions such as ELISAs, may be less forgiving (Zimmerman, Li, Yarbrough, Slebos, & Liebler, 2012). 
In this pilot study the protein of interest, adiponectin, is a cytokine-like protein secreted by adipose tissue. Adiponectin 
has insulin-sensitising, anti-atherogenic, anti-inflammatory, anti-neoplastic and cerebroprotective properties (Hickman 
& Whitehead, 2012). It undergoes post-translational modification and multimerisation prior to secretion (Simpson & 
Whitehead, 2010) and circulates in multimers termed low molecular weight (LMW; trimer and hexamer) and high 
molecular weight (HMW; 12- to 18mers) (Hickman & Whitehead, 2012; Tsao, 2013). In diseases such as obesity and 
type 2 diabetes, adiponectin levels are decreased and this reflects a selective reduction in the levels of the HMW 
multimers. The HMW multimers are more metabolically active than LMW and are more closely correlated with health 
and disease than the total levels (Hickman & Whitehead, 2012; Pajvani et al., 2004). Therefore, estimation of the HMW 
adiponectin in circulation is of greater clinical relevance. In light of this, there have been several studies examining the 
stability of total and HMW adiponectin under a range of laboratory processing conditions. Such investigations have 
demonstrated that both total (Suominen, 2004) and HMW adiponectin (Sattar et al., 2008; Schraw, Wang, Halberg, 
Hawkins, & Scherer, 2008) are relatively stable in serum and plasma when subjected to multiple freeze-thaw cycles. 
However, the effect of pre-processing conditions such as the temperature and length of time that a blood sample may be 
stored and transported prior to centrifugation, separating serum or plasma from cells and subsequent storage of serum or 
plasma is still unclear. Total adiponectin has been shown to be stable for up to 36 h in Styrofoam containers containing 
ice packs prior to centrifugation in EDTA and sodium heparin samples (Pischon, Hotamisligil, & Rimm, 2003). 
However, the effects of processing delays and prolonged blood sample storage on HMW adiponectin specifically have 
not been investigated to our knowledge. We hypothesise that variation in serum or plasma separation from cells post 
storage at different temperature and length of time may effect the concentration of adiponectin in serum and plasma. 
This pilot study aimed to investigate the stability of total and HMW adiponectin in EDTA plasma and serum samples, 
stored for 6 h and 72 h at 4°C and 6 h at room temperature (RT), measured using commercially available enzyme-linked 
immunosorbent assays (ELISAs) that specifically detect monomeric or HMW adiponectin. 
2. Materials and Methods 
2.1 Subjects 
This prospective, observational pilot study recruited eight healthy participants with informed written consent in 
accordance with the principles of the Declaration of Helsinki and requirements of the Princess Alexandra Hospital 
Human Research Ethics Committee. All participants were non-smoking, lean (body mass index calculated as weight 
(kilograms) / height (metres)
2
; range between 20-25kg/m
2
) and with no history of liver, metabolic, kidney or 
cardiovascular dysfunction.  
2.2 Processing of Serum and Plasma Samples 
At a single time-point (between 7am-8am) fasting blood (>8 h overnight fast) was drawn into 8 vacutainer tubes (4 
EDTA and 4 serum per participant for analysis of plasma (4 x EDTA tubes - Cat# 454023, clot activator tubes - 
Cat#456071, Greiner Bio-One. Kremsmunster, Austria), respectively. Tubes were then either processed with minimal 
storage (ideal) or following storage at room temperature (RT 24
o
C; uncentrifuged on bench top) for 6 h or after storage 
at 4
oC for 6 h and 72 h respectively. Comparative or „ideal‟ processing involved a maximum of 15 min storage at 4oC 
followed by centrifugation at 3000 rpm at RT for 10 min. Samples were then aliquoted into Eppendorf tubes and stored 
at -80
o
C for 1 month until analysis. Samples stored in vacutainer tubes for 6 h at RT or for 6 h or 72 h at 4°C prior to 
centrifugation were processed as per ideal conditions (described above) to allow for comparison of the effects of 
delayed processing. Samples were all analysed in duplicate and 3 internal controls were incorporated on each plate. 
2.3 Adiponectin Measurement 
Total and HMW adiponectin were analysed by antibody specific based assays (R&D Systems, Minneapolis, MN, USA). 
In-house intra- and inter-assay CVs were 6.1% & 14.1% and 3.2% & 8.7% for total and HMW adiponectin respectively.  
2.4 Statistical Analysis 
Data were normally distributed (Kolmogorov-Smirnov Test) and are reported as means (±SD) or mean differences (95% 
CI). Paired student t-tests were used to compare differences between the comparative (ideal) and test conditions (for 
total and HMW adiponectin) for both the serum and plasma sample types at identical time points and between the 
different storage conditions (ideal, 72 h at 4°C, 6 h at 4°C and 6 h at RT). To account for multiple comparisons 
(maximum of four comparisons) statistical significance was set at p<0.0125 (two-tailed). All analyses were performed 
using IBM SPSS Statistics for Windows (version 22.0, Armonk, NY: IBM Corp). A greater than 15% difference in 
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samples was deemed clinically significant as this is a change typically observed in studies with drug therapy targets 
(Gaich et al., 2013; Phillips et al., 2009). 
3. Results 
The participants (male n=4; female n=4) had a mean body mass index 22.7 (±2.2) kg/m
2
 and mean age 32.8 (±8.0) 
years. 
3.1 Effect of Sample Type and Prolonged Storage on the Stability of Total and HMW Adiponectin 
A. 72 h storage at 4°C 
Table 1 summarises the total and HMW adiponectin results in serum and plasma under ideal conditions and after a 72 
hour delay in processing. Under comparative or “ideal” blood handling conditions serum yielded significantly higher 
total and HMW adiponectin concentrations than plasma (mean difference: -1.3 µg/mL [95% CI: -1.6, -1.0], p<0.001; 
and, -0.6 µg/mL [95% CI: -0.7, -0.5], p<0.001, respectively). Prolonged blood storage, 72 h at 4°C, resulted in a 
decrease in serum total adiponectin levels compared with ideal conditions (mean difference: -1.4 µg/mL [95% CI: -2.0, 
-0.8], p=0.001), whereas serum HMW adiponectin concentrations were similar (mean difference: -0.2 µg/mL [95% CI: 
-0.5, 0.0], p=0.074). In contrast, in plasma, total adiponectin concentrations were not statistically significantly different 
after 72 h storage compared with ideal conditions (mean difference: -0.3 µg/mL [95% CI: -1.5, 0.8], p=0.511) whereas 
HMW adiponectin levels significantly decreased after 72 h storage at 4°C (mean difference: -0.6 µg/mL [95%CI: -0.9, 
-0.2], p=0.007). The significant differences observed between serum and plasma for total and HMW adiponectin 
concentrations under ideal handling remained after 72 h of storage at 4°C for HMW adiponectin only (mean difference: 
-0.9 µg/ml [95% CI: -1.4, -0.4], p=0.003).  
Table 1. Total and high molecular weight (HMW) measured in serum and plasma. Measurements under ideal handling 
conditions or after 72 h delay in sample processing (n=8). 
 Total Adiponectin (µg/mL) HMW Adiponectin (µg/mL) 
Ideal 72 h  pa Mean % difference Ideal 72 h  pa Mean % difference 
Serum 7.2 ± 1.9 5.8 ± 2.0 0.001 19.4 4.2 ± 1.4 3.9 ± 1.6 0.074 7.1 
Plasma 6.0 ± 1.8* 5.6 ± 2.2 0.511 6.7 3.6 ± 1.3* 3.0 ± 1.3 0.007 16.7 
(Data are mean ± SD, 
a 
p-value comparing ideal handling and after 72 h delay (paired t-tests), * p<0.01 (paired t-test 
comparing serum and plasma), Mean % difference calculated as the mean percent change between ideal and 72 h 
storage conditions in serum and plasma.) 
B. 6 h storage at 4°C and Room Temperature (RT)  
Having established there was a significant decrease in serum total adiponectin concentrations after 72 h blood storage 
at 4°C we then investigate whether a 6 h delay at 4°C or at RT might also affect total adiponectin concentrations, as 
these conditions may reflect those expected to occur in a clinical setting. 
Compared with ideal conditions, a significant decrease in serum total adiponectin concentrations was observed when 
stored for 6 h at 4°C (mean difference: -0.7 µg/ml [95% CI: -1.1, -0.4], p=0.002) and for 6 h at RT (mean difference: 
-0.8 µg/ml [95% CI: -1.3, -0.4], p=0.003), similar to that observed after blood storage for 72 h (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effects of time and temperature on measurement of total adiponectin levels in serum 
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Total adiponectin levels after delay in sample processing at 4°C for 6 or 72 h, or at RT for 6 h (n = 8; each sample 
measured in duplicate on x2 separate ELISA kits; paired student t-tests were used to compare differences between the 
comparative (ideal) and test condition; **p<0.010). (Ideal - refers to comparative handling conditions; 6h - blood 
sample stored for 6 hours at 4
o
C; 72h - blood sample stored for 72 hours at 4
o
C; 6hRT - blood sample stored for 6 hours 
at room temperature.) 
4. Discussion 
This findings of this study suggests that delays in processing of blood samples may result in clinically significant lower 
concentrations of total adiponectin in serum and lower concentrations of HMW adiponectin in plasma using the 
describe ELISA assay. Reductions in total adiponectin concentrations were detectable both when blood tube storage 
was at room temperature and when refrigerated at 4 degrees Celsius.  
The development of both total adiponectin and HMW specific antibodies has provided investigators with the 
opportunity to explore the relationship between adiponectin profiles and disease in large cohorts and or longitudinal 
studies that was hitherto unrealistic. This has also prompted several investigations exploring the influence of 
sample-handling and storage variation on the stability of total and HMW adiponectin (Sattar et al., 2008; Schraw et al., 
2008; Suominen, 2004). Such studies show that both total and HMW adiponectin are stable in serum or plasma when 
subjected to multiple freeze-thaw cycles (Sattar et al., 2008; Schraw et al., 2008; Suominen, 2004). Furthermore, total 
adiponectin has been reported to be stable in blood for up to 36 h, in Styrofoam containers containing ice packs, prior to 
processing for measurement in plasma (Pischon et al., 2003). In this study we extended the pre-analytical storage 
conditions, which is more in line with what occurs in remote collection centres using EDTA plasma and serum samples 
for total adiponectin as well as the more metabolically active HMW multimers. The data showed that the total and 
HMW adiponectin concentrations were affected by the pre-analytical processes.  
Delays in processing blood samples had modest but significant and differential effects on the concentrations of total and 
HMW adiponectin in serum and plasma respectively. In serum, there was a mean 20% reduction in total adiponectin 
concentrations following extended (72h at 4
o
C) storage of blood whilst concentrations of HMW adiponectin were 
relatively unaffected. These observations suggest enhanced stability of HMW adiponectin relative to LMW adiponectin 
in serum, at least under these handling conditions. One possibility is that the extensive post-translational modifications 
(PTMs) required for the efficient multimerisation and secretion of HMW adiponectin enhance its stability. Such PTMs 
include hydroxylation and glycosylation of conserved lysines situated within the collagenous stalk of adiponectin 
(Richards et al., 2006; Wang et al., 2006) and, consistent with the above, these have been shown to make HMW 
adiponectin refractory to digestion by proteinase K (Peake, Hughes, Shen, & Charlesworth, 2007). Interestingly, in 
serum we also observed a similar decrease in total adiponectin concentrations following a 6 h delay at either 4
o
C or RT, 
suggesting that time, rather than temperature, is of the essence when processing blood samples for total adiponectin 
analysis in serum. 
Furthermore the sample type had an influence on the stability as after 72 h delay in sample processing, total adiponectin 
decreased to a greater extent in serum than in plasma, and in contrast HMW adiponectin decreased to a greater extent in 
plasma but not in serum. In addition to PTMs, calcium has been reported as important for the formation (Yu, Zhang, 
Wang, & Qin, 2013) and stability (Banga et al., 2008) of HMW adiponectin. Using differential centrifugation and 
SDS-PAGE/Western blot to analyse adiponectin multimer profiles, Banga and colleagues demonstrated marked 
dissociation of HMW to LMW multimers in EDTA plasma when compared with serum from four subjects (Banga et al., 
2008). In comparison to these observations, we observed a smaller, albeit statistically significant and clinically 
meaningful, 15% decrease in HMW adiponectin concentrations when blood samples were stored for 72 h in EDTA 
plasma tubes prior to processing. However we note the harsher forces that samples processed by sucrose gradient 
velocity sedimentation are subject to compared to the relatively mild conditions of an ELISA. That we observed no 
decrease in total plasma adiponectin levels after delayed processing of blood samples appears consistent with a report 
where total plasma adiponectin was unaffected following storage of blood samples as described by Pischon and 
colleagues (Pischon et al., 2003). In contrast Pischon and colleagues showed EDTA plasma samples led to an increase 
in total adiponectin levels of almost 20% (p=0.05), in contrast to plasma samples collected in sodium-heparin, 
prompting the authors to suggest that the apparent increase in the presence of EDTA may reflect dissociation of the 
HMW adiponectin multimers resulting in enhanced detection of lower order multimers by the antibodies in the ELISA 
(Pischon et al., 2003). Collectively then, stability of the HMW multimers appears, at least in this small study, to be 
dependent on a variety of complementary factors including the degree of PTM and presence of calcium (Hickman & 
Whitehead, 2012; Richards et al., 2006; Simpson & Whitehead, 2010; Wang et al., 2006). Hence, the effect of 
perturbing any of these parameters is likely to affect multimer stability in a context-dependent manner. Given the 
number of PTMs is variable between individuals and across multimers (Richards et al., 2006; Wang et al., 2006), and 
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that calcium content may also vary, there is likely to be some degree of variability between subjects although this study 
was not designed to address this question. 
The results of this pilot study suggest that adhering to ideal (standardised and optimised) processing conditions is 
desirable in studies looking for differences in both total and HMW adiponectin concentrations. If that is not achievable, 
from our results the option which is least susceptible to differences in sample handling would be to measure HMW 
adiponectin in serum. For total adiponectin it is possible to store plasma samples for 6-72 h at 4°C prior to processing to 
reduce variability. Based on the current findings we suggest that sample processing conditions should be optimised and 
standardised before commencing studies and include tight protocols around time and temperature conditions when 
blood samples need to be handled by different laboratories or transported between sites. Protocols which reduce 
handling time are most recommended but consistency across all sample collection is most critical regardless of protocol.  
A limitation of this pilot study is the small number of participants, all of whom were lean and healthy. Even with this 
small sample we observed statistically significant and clinically meaningful differences between most sample 
conditions indicating that larger studies in more heterogeneous groups are warranted. For comparisons where 
non-significant differences were observed, the confidence intervals could not conclusively rule out meaningful effects 
as unlikely, with the exception of the comparison of HMW adiponectin between ideal and 72 h delay in serum. While 
the degree of variation in stability of adiponectin between individuals is unknown, as mentioned above, given that 
PTMs contribute to adiponectin multimerisation and stability and that the number of PTMs such as glycosylation are 
reduced in diseases such as type 2 diabetes (Richards et al., 2006; Wang et al., 2006), further and more extensive studies 
are required to determine whether stability is comparable across disease populations. 
Notwithstanding, this pilot study demonstrates that delays in processing of blood samples collected for analysis, be it 
plasma or serum, may result in decreases in total and or HMW adiponectin measures hence consistency at this step is 
recommended and delays should, wherever possible, be avoided. 
In conclusion, pre-analytical conditions variations, such as delay in processing blood samples, may result in a reduced 
concentration of total and HMW adiponectin in serum and plasma respectively. Larger studies designed to identify the 
effect of different pre-analytical conditions in blood handling procedures in large multi-site clinical trials are warranted.  
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